Multimodality therapy for stage III non-small-cell lung cancer.

  title={Multimodality therapy for stage III non-small-cell lung cancer.},
  author={Daniel Farray and Nena Mirkovic and Kathy S. Albain},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  volume={23 14},
The treatment of stage III non-small-cell lung cancer has evolved over the last two decades, with combined-modality therapy the current standard of care. As a result, intermediate and long-term survival has improved for patients in this common stage category, compared to the poor outcomes achieved with the historical standard of once-daily radiation therapy… CONTINUE READING